Sandra L Nagale

20130072855, Mar 21, 2013

Aug 30, 2012

13/599916

John Sherry - Needham MA, US
Sandra Nagale - Lowell MA, US

Boston Scientific Scimed, Inc. - Maple Grove MN

A61M 5/00
A61M 37/00
A61M 25/00

604 22, 604506

Embodiments of the disclosure may include a method of treatment. The method of treatment may include advancing a medical device to a wall of an organ having a plurality of layers of tissue. The medical device may include an elongate tube having a proximal end and a distal end, a lumen extending therebetween, and an injector disposed within the lumen. The injector may be configured to deliver a substance to a location between first and second layers of tissue of the plurality of layers of tissue within the organ wall. In addition, the method may further include delivering the substance to the location, wherein, when delivered, the substance is configured to spatially separate a portion of the first and second layers of the tissue.

20130218027, Aug 22, 2013

Feb 19, 2013

13/770564

Sandra Nagale - Lowell MA, US

BOSTON SCIENTIFIC SCIMED, INC. - Maple Grove MN

A61B 5/00

600478

In one embodiment, a medical device includes a first optical fiber, a second optical fiber, a third optical fiber, and a fourth optical fiber. The first optical fiber is operatively coupled to a first electromagnetic radiation source and is configured to transmit electromagnetic radiation to bodily tissue. The second optical fiber is configured to receive electromagnetic radiation from the first electromagnetic radiation source scattered by the bodily tissue. The third optical fiber is operatively coupled to a second electromagnetic radiation source and is configured to transmit electromagnetic radiation to bodily tissue. The second electromagnetic radiation source is different than the first electromagnetic radiation source. The fourth optical fiber is configured to receive electromagnetic radiation from the second electromagnetic radiation source scattered by the bodily tissue.

20130018281, Jan 17, 2013

Jun 28, 2012

13/535741

Sandra Nagale - Lowell MA, US
Ruth Cheng - Natick MA, US

A61B 5/20

600587

A medical device for monitoring physical, chemical, or biological characteristics of an organ, such as the urinary bladder. The medical device may include an elongate member having a proximal end and a distal end. The device may further include an end-effector assembly extending distally from the distal end of the elongate member. The end-effector assembly may also include a plurality of sensing elements for detecting abnormal organ function. Each of the plurality of sensing elements may include one or more of mechanical, visual, chemical, and biological sensors.

20210128921, May 6, 2021

Jan 11, 2021

17/145514

- Valencia CA, US
Bryan Allen Clark - Forest Lake MN, US
Elizabeth Mary Annoni - White Bear Lake MN, US
Sandra Nagale - Bolton MA, US
Pramodsingh Hirasingh Thakur - Woodbury MN, US
Jianwen Gu - Valencia CA, US

A61N 1/36
A61N 1/05
A61B 5/16
A61B 5/00
G16H 20/70
A61B 5/11
G16H 50/30
G16H 40/63

This document discusses, among other things, systems and methods for managing pain in a subject. A system may include one or more sensors configured to sense from the subject information corresponding to emotional reaction to pain, such as emotional expression. The emotional expression includes facial or vocal expression. A pain analyzer circuit may generate a pain score using signal metrics of facial or vocal expression extracted from the sensed information. The pain score may be output to a user or a process. The system may additionally include a neurostimulator that can adaptively control the delivery of pain therapy by automatically adjusting stimulation parameters based on the pain score.

20200297409, Sep 24, 2020

Jun 2, 2020

16/890395

- Maple Grove MN, US
Mark W. Boden - Harrisville RI, US
Sandra Nagale - Bolton MA, US

A61B 18/14

In one aspect, the present disclosure is directed to methods of treating various conditions including bladder conditions in a patient, comprising: positioning at least one ablative element of an ablative device on or over an adventitial surface of the bladder; and using the ablative device to denervate bladder nerve fibers. Other aspects of the present disclosure pertain, for example, to devices and kits for of treating bladder conditions.

20190150851, May 23, 2019

Nov 13, 2018

16/188669

- Maple Grove MN, US
Elizabeth Mary Annoni - White Bear Lake MN, US
Sandra Nagale - Bolton MA, US
Jeffrey E. Stahmann - Ramsey MN, US
Kyle Harish Srivastava - Saint Paul MN, US
Mark W. Boden - Harrisville RI, US
Martin Phelan - Sussex NJ, US
George Wilfred Duval - Sudbury MA, US

A61B 5/00
C07K 16/24
A61B 5/024

An example of a system for monitoring and treating a medical condition of a patient may include signal inputs to receive patient condition signals indicative of a state of inflammatory bowel disease (IBD), a signal processing circuit configured to process the patient condition signals and generate patient condition parameters indicative of the state of IBD using the processed patient condition signals, and a medical condition analyzer configured to analyze the patient condition parameters and determine the medical condition including the state of IBD using an outcome of the analysis. The patient condition parameters may include one or more physiological marker parameters each representative of a physiological marker of IBD and one or more quality of life parameters each being measure of quality of life of the patient.

20180193652, Jul 12, 2018

Jan 11, 2018

15/867873

- Valencia CA, US
Bryan Allen Clark - Forest Lake MN, US
Elizabeth Mary Annoni - White Bear Lake MN, US
Sandra Nagale - Bolton MA, US
Pramodsingh Hirasingh Thakur - Woodbury MN, US
Jianwen Gu - Valencia CA, US

A61N 1/36
A61B 5/16
A61B 5/00
A61N 1/05

This document discusses, among other things, systems and methods for managing pain in a subject. A system may include one or more sensors configured to sense from the subject information corresponding to emotional reaction to pain, such as emotional expression. The emotional expression includes facial or vocal expression. A pain analyzer circuit may generate a pain score using signal metrics of facial or vocal expression extracted from the sensed information. The pain score may be output to a user or a process. The system may additionally include a neurostimulator that can adaptively control the delivery of pain therapy by automatically adjusting stimulation parameters based on the pain score.

20180153476, Jun 7, 2018

Nov 29, 2017

15/826296

- St. Paul MN, US
Pramodsingh Hirasingh Thakur - Woodbury MN, US
Qi An - Blaine MN, US
Sandra Nagale - Bolton MA, US
Bryan Allen Clark - Forest Lake MN, US
Thomas Christen - Needham MA, US
Edward A. Goldberg - San Diego CA, US

A61B 5/00
A61B 5/0205
G06F 19/00

This document discusses, among other things, systems and methods for detecting stroke. A system may comprise a sensor circuit for sensing a physiological signal, and a second sensor to detect a physical state change. The physical state change may include a transition in physical activity, posture, or sleep state. A stroke risk circuit may detect, from the sensed physiological signal, a signal indicative of blood pressure surge (BPS) in response to one or more physical state changes. The system may generate a stroke risk indicator indicating a risk of developing an impending stroke event using the detected BPS. The system includes an output unit that outputs the stroke risk indicator to a user or a process.